Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 13,294 | 15,881 | 11,834 | 7,884 | 7,027 |
Operating Income | -13,294 | -15,881 | -11,834 | -7,884 | -7,027 |
Other Income | 45 | 131 | 308 | 175 | 183 |
Pre-tax Income | -13,249 | -15,750 | -11,526 | -7,709 | -6,844 |
Net Income Continuous | -13,249 | -15,750 | -11,526 | -7,709 | -6,844 |
Net Income | $-13,249 | $-15,750 | $-11,526 | $-7,709 | $-6,844 |
EPS Basic Total Ops | -2.25 | -3.15 | -2.25 | -1.95 | -1.80 |
EPS Basic Continuous Ops | -2.31 | -3.10 | -2.27 | -1.93 | -1.85 |
EPS Diluted Total Ops | -2.25 | -3.15 | -2.25 | -1.95 | -1.80 |
EPS Diluted Continuous Ops | -2.31 | -3.10 | -2.27 | -1.93 | -1.85 |
EBITDA(a) | $-13,141 | $-15,730 | $-11,678 | $-7,732 | $-6,879 |